** Shares of Emyria Ltd EMD.AX fall as much as 6.1% to A$0.062, their biggest intraday pct loss since November 12

** The early-stage drug developer says firm commitments received to raise A$8 million ($5.19 million) at an issue price of A$0.06 per share

** Offer price at a 9.09% discount to the stock's last close

** Funds will be used for expansion of Emyria's East Coast clinical footprint during CY2026, others

** About 3.9 million shares traded, 1.4x the 30-day average

** YTD, stock up 83.4%, including current session's move

($1 = 1.5427 Australian dollars)

(Reporting by Ananya Verma in Bengaluru)

((ananya.verma@thomsonreuters.com;))